Baseline Characteristics of HF Patients with LVSD | Before PSM | After 1:1 PSM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CAD Cohort (N = 15,827 ) | Non-CAD Cohort (N = 6,403) | CAD Cohort (N = 5,792 ) | Non-CAD Cohort (N = 5,792) | |||||||||
N/Mean | %/SD | N/Mean | %/SD | p-value | Std | N/Mean | %/SD | N/Mean | %/SD | p-value | Std | |
Age (Mean) | 79.8 | 8.3 | 80.9 | 8.7 | <.0001 | 13.0 | 80.8 | 8.5 | 80.7 | 8.6 | 0.4521 | 1.4 |
Age Group | ||||||||||||
65-74 | 4,849 | 30.6% | 1,714 | 26.8% | <.0001 | 8.6 | 1,566 | 27.0% | 1,573 | 27.2% | 0.8837 | 0.3 |
75-84 | 6,068 | 38.3% | 2,296 | 35.9% | 0.0005 | 5.1 | 2,123 | 36.7% | 2,113 | 36.5% | 0.8470 | 0.4 |
85+ | 4,910 | 31.0% | 2,393 | 37.4% | <.0001 | 13.4 | 2,103 | 36.3% | 2,106 | 36.4% | 0.9538 | 0.1 |
Gender | ||||||||||||
Male | 7,852 | 49.6% | 2,278 | 35.6% | <.0001 | 28.7 | 2,200 | 38.0% | 2,174 | 37.5% | 0.6183 | 0.9 |
Female | 7,975 | 50.4% | 4,125 | 64.4% | <.0001 | 28.7 | 3,592 | 62.0% | 3,618 | 62.5% | 0.6183 | 0.9 |
Race/Ethnicity | ||||||||||||
White | 13,636 | 86.2% | 5,212 | 81.4% | <.0001 | 12.9 | 4,802 | 82.9% | 4,787 | 82.6% | 0.7120 | 0.7 |
Black | 1,436 | 9.1% | 924 | 14.4% | <.0001 | 16.7 | 755 | 13.0% | 760 | 13.1% | 0.8904 | 0.3 |
Hispanic | 145 | 0.9% | 57 | 0.9% | 0.8535 | 0.3 | 44 | 0.8% | 50 | 0.9% | 0.5344 | 1.2 |
Asian | 206 | 1.3% | 65 | 1.0% | 0.0780 | 2.7 | 51 | 0.9% | 63 | 1.1% | 0.2587 | 2.1 |
Native American | 285 | 1.8% | 110 | 1.7% | 0.6723 | 0.6 | 112 | 1.9% | 101 | 1.7% | 0.4468 | 1.4 |
Other | 92 | 0.6% | 23 | 0.4% | 0.0366 | 3.2 | 22 | 0.4% | 23 | 0.4% | 0.8813 | 0.3 |
Unknown | 27 | 0.2% | 12 | 0.2% | 0.7861 | 0.4 | 6 | 0.1% | 8 | 0.1% | 0.5928 | 1.0 |
US Geographic Region | ||||||||||||
Northeast | 3,219 | 20.3% | 1,271 | 19.9% | 0.4113 | 1.2 | 1,170 | 20.2% | 1,165 | 20.1% | 0.9078 | 0.2 |
Midwest | 4,149 | 26.2% | 1,641 | 25.6% | 0.3673 | 1.3 | 1,459 | 25.2% | 1,491 | 25.7% | 0.4950 | 1.3 |
South | 6,370 | 40.2% | 2,506 | 39.1% | 0.1260 | 2.3 | 2,265 | 39.1% | 2,284 | 39.4% | 0.7177 | 0.7 |
West | 2,051 | 13.0% | 970 | 15.1% | <.0001 | 6.3 | 882 | 15.2% | 838 | 14.5% | 0.2503 | 2.1 |
Other | 38 | 0.2% | 15 | 0.2% | 0.9357 | 0.1 | 16 | 0.3% | 14 | 0.2% | 0.7146 | 0.7 |
Comorbidity Indices | ||||||||||||
Charlson Comorbidity Index | 4.4 | 2.5 | 3.5 | 2.5 | <.0001 | 34.5 | 3.7 | 2.1 | 3.7 | 2.6 | 0.1720 | 2.5 |
CHADS2 Score | 3.3 | 1.2 | 3.0 | 1.1 | <.0001 | 26.8 | 3.1 | 1.1 | 3.1 | 1.1 | 0.5115 | 1.2 |
Comorbid Conditions | ||||||||||||
Hypertension | 12,772 | 80.7% | 4,756 | 74.3% | <.0001 | 15.4 | 4,397 | 75.9% | 4,384 | 75.7% | 0.7779 | 0.5 |
Hyperlipidemia | 10,716 | 67.7% | 2,993 | 46.7% | <.0001 | 43.4 | 2,896 | 50.0% | 2,937 | 50.7% | 0.4461 | 1.4 |
Anemia | 7,298 | 46.1% | 2,862 | 44.7% | 0.0554 | 2.8 | 2,614 | 45.1% | 2,607 | 45.0% | 0.8960 | 0.2 |
Diabetes | 7,320 | 46.3% | 2,292 | 35.8% | <.0001 | 21.4 | 2,201 | 38.0% | 2,179 | 37.6% | 0.6734 | 0.8 |
Chronic Renal Insufficiency | 5,078 | 32.1% | 1,738 | 27.1% | <.0001 | 10.8 | 1,670 | 28.8% | 1,632 | 28.2% | 0.4342 | 1.5 |
Arrhythmia | 4,804 | 30.4% | 1,487 | 23.2% | <.0001 | 16.2 | 1,435 | 24.8% | 1,424 | 24.6% | 0.8126 | 0.4 |
Pneumonia | 3,994 | 25.2% | 1,864 | 29.1% | <.0001 | 8.7 | 1,707 | 29.5% | 1,651 | 28.5% | 0.2515 | 2.1 |
Trauma | 4,064 | 25.7% | 1,734 | 27.1% | 0.0309 | 3.2 | 1,596 | 27.6% | 1,563 | 27.0% | 0.4912 | 1.3 |
Malignant Neoplasm | 3,533 | 22.3% | 1,404 | 21.9% | 0.5207 | 1.0 | 1,313 | 22.7% | 1,273 | 22.0% | 0.3721 | 1.7 |
Peripheral Arterial Disease | 3,663 | 23.1% | 834 | 13.0% | <.0001 | 26.5 | 783 | 13.5% | 814 | 14.1% | 0.4035 | 1.6 |
Chronic Obstructive Pulmonary Disease | 2,576 | 16.3% | 1,056 | 16.5% | 0.6929 | 0.6 | 968 | 16.7% | 962 | 16.6% | 0.8811 | 0.3 |
Dementia | 1,725 | 10.9% | 884 | 13.8% | <.0001 | 8.8 | 770 | 13.3% | 768 | 13.3% | 0.9563 | 0.1 |
Anasarca | 1,666 | 10.5% | 899 | 14.0% | <.0001 | 10.7 | 738 | 12.7% | 757 | 13.1% | 0.5985 | 1.0 |
Prior Ischemic Stroke | 2,685 | 17.0% | 696 | 10.9% | <.0001 | 17.7 | 701 | 12.1% | 673 | 11.6% | 0.4210 | 1.5 |
Prior Transient Ischemic Attack | 625 | 3.9% | 192 | 3.0% | 0.0006 | 5.2 | 175 | 3.0% | 183 | 3.2% | 0.6676 | 0.8 |
Prior Venous Thromboembolism | 912 | 5.8% | 535 | 8.4% | <.0001 | 10.1 | 436 | 7.5% | 429 | 7.4% | 0.8046 | 0.5 |
Prior Major Bleeding* | 597 | 3.8% | 272 | 4.2% | 0.0973 | 2.4 | 225 | 3.9% | 239 | 4.1% | 0.5071 | 1.2 |
Commander Criteria | ||||||||||||
Documented previous CAD | 15,787 | 99.75% | 0 | 0.00% | N/A | 5,775 | 99.71% | 0 | 0.00% | N/A | ||
History of prior Coronary Artery Bypass Graft (CABG) | 933 | 5.89% | 0 | 0.00% | 273 | 4.71% | 0 | 0.00% | ||||
History of percutaneous coronary intervention (PCI) with or without stent | 2,430 | 15.35% | 0 | 0.00% | 730 | 12.60% | 0 | 0.00% |